Respiratory symptoms and long-term cardiovascular mortality

Respiratory Medicine

Volumn 101, Issue 11, 2007, Pages 2289-2296

  Frostad, Anne ^a,c   Soyseth, Vidar ^b   Haldorsen, Tor ^a   Andersen, Aage ^a   Gulsvik, Amund ^c  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Cohort study; Ischaemic heart disease; Mortality; Respiratory symptoms; Stroke

Indexed keywords

ADOLESCENT; ADULT; AGED; AIR POLLUTION; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWAY; OCCUPATIONAL EXPOSURE; PREDICTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SCORING SYSTEM; SMOKING HABIT; STROKE; SYMPTOM;

ADOLESCENT; ADULT; AGED; ASTHMA; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NORWAY; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RESPIRATION DISORDERS; RISK FACTORS; SMOKING; STROKE;

EID: 34848887489     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.06.023     Document Type: Article

References (34)

1. Mannino D.M., Ford E.S., and Redd S.C. Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination. Am J Med 114 9 (2003) 758-762
2. Sin D.D., and Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107 11 (2003) 1514-1519
3. Sin D.D., and Man S.F. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 83 1 (2005) 8-13
4. Hole D.J., Watt G.C., Davey-Smith G., Hart C.L., Gillis C.R., and Hawthorne V.M. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313 7059 (1996) 711-715
5. Engstrom G., Wollmer P., Hedblad B., Juul-Moller S., Valind S., and Janzon L. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from "men born in 1914," Malmo, Sweden. Circulation 103 25 (2001) 3086-3091
6. Iadecola C., and Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 14 1 (2001) 89-94
7. Altay T., Gonzales E.R., Park T.S., and Gidday J.M. Cerebrovascular inflammation after brief episodic hypoxia: modulation by neuronal and endothelial nitric oxide synthase. J Appl Physiol 96 3 (2004) 1223-1230
8. Frostad A., Soyseth V., Andersen A., and Gulsvik A. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med 259 5 (2006) 520-529
9. Frostad A., Soyseth V., Haldorsen T., Andersen A., and Gulsvik A. Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia. Thorax 61 11 (2006) 951-956
10. Statistics Norway. Statistical Yearbook of Norway, http://www.ssb.no/vis/english/subjects/03/01/10/dodsarsak_en/art-2006-06 -01-01-en.html. 2007.
11. Gulsvik A. Prevalence of respiratory symptoms in the city of Oslo. Scand J Respir Dis 60 5 (1979) 275-285
12. World Health Organization. International statistical classification of diseases and related health problems: ICD-10. World Health Organization. 10th ed. Genova, 1992.
13. Cox D.R. Regression models and life-tables. J Roy Statist Soc (B) 34 (1972) 187-220
14. Korn E.L., Graubard B.I., and Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145 1 (1997) 72-80
15. Thiebaut A.C., and Benichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 23 24 (2004) 3803-3820
16. Marubini E, Valsechi MG. Validation of the proportional hazard models. In: Analysing survival data from clinical trials and observational studies. West Sussex: Wiley; 2004: p. 223-265.
17. StataCorporation Stata statistical software, release 9.0. College Station, TX, 2005.
18. Gjertsen F. The Norwegian causes of death register-an important data source for medical research. Tidsskr Nor Laegeforen 122 (2002) 2551-2554
19. Johansson L., and Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol 29 (2000) 494-502
20. Rothman KJ. Greenland s. Precision and Validity in Epidemiologic Studies. In: Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins; 1998.
21. Stavem K., Aaser E., Sandvik L., Bjornholt J.V., Erikssen G., Thaulow E., et al. Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 25 4 (2005) 618-625
22. Eagan T.M., Bakke P.S., Eide G.E., and Gulsvik A. Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study. Eur Respir J 19 4 (2002) 599-605
23. Statistics Norway. Statistics Norway, 2005, 〈http://statbank.ssb.no/statistikkbanken/〉.
24. Ronneberg A., Lund K.E., and Hafstad A. Lifetime smoking habits among Norwegian men and women born between 1890 and 1974. Int J Epidemiol 23 2 (1994) 267-276
25. Eagan T.M., Gulsvik A., Eide G.E., and Bakke P.S. Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. Eur Respir J 23 4 (2004) 589-594
26. Stavem K., Sandvik L., and Erikssen J. Breathlessness, phlegm and mortality: 26 years of follow-up in healthy middle-aged Norwegian men. J Intern Med 260 4 (2006) 332-342
27. Jousilahti P., Vartiainen E., Tuomilehto J., and Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 348 9027 (1996) 567-572
28. Todd G.F., Hunt B.M., and Lambert P.M. Four cardiorespiratory symptoms as predictors of mortality. J Epidemiol Community Health 32 4 (1978) 267-274
29. Lange P., Ulrik C.S., and Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 347 9011 (1996) 1285-1289
30. Rosengren A., and Wilhelmsen L. Respiratory symptoms and long-term risk of death from cardiovascular disease, cancer and other causes in Swedish men. Int J Epidemiol 27 6 (1998) 962-969
31. Knuiman M.W., James A.L., Divitini M.L., Ryan G., Bartholomew H.C., and Musk A.W. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 9 5 (1999) 297-306
32. Vandentorren S., Baldi I., Annesi M.I., Charpin D., Neukirch F., Filleul L., et al. Long-term mortality among adults with or without asthma in the PAARC study. Eur Respir J 21 3 (2003) 462-467
33. Lindahl B., Toss H., Siegbahn A., Venge P., and Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. N Engl J Med 343 16 (2000) 1139-1147
34. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 7255 (2000) 199-204